Key facts
- Notable investors include US National Science Foundation, Spacecadet Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dinya
- ·The full record, as it builds
Funding rounds
No funding rounds for Dinya are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dinya
Operator of a biotechnology company intended to develop DNA synthesis technology. The company's technology helps to create gene-length DNA, enabling therapeutics, biomanufacturing and agriculture industries to get new and valuable insights.
- Sector
- Healthcare
- HQ
- Raleigh, NC, United States
- Founded
- 2021
- Employees
- 3
- Website
- dinyadna.com/
- Ownership
- Privately Held (backing)
Dinya doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dinya shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dinya in its N-PORT filings yet. We sweep new filings monthly.